Faculty Collaboration Database

1. Gordon-Strachan, G., Cunningham‐Myrie, C., Fox, K., Kirton, C., Fraser, R., McLeod, G., & Forrester, T. Richer but fatter: the unintended consequences of microcredit financing on household health and expenditure in Jamaica. Tropical Medicine & International Health, 2007; 20(1), 67-76.

2. King L, Fraser R, Forbes M, Grindley M, Ali S, Reid M. Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen. 2007;14(3):117-22.

3. Ali, S., Fraser, R., Reid, M., & Ali, A. Seizures predict increased mortality in patients with sickle cell disease (SCD). In Epilepsia 2008, Jan. (vol. 49, pp. 242-243).

4. Cumming V, King L, Fraser R, Serjeant G, Reid M. Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia. Br J Haematol. 2008 Jul;142(1):119-25.

5. Hardie R, King L, Fraser R, Reid M. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening. Ann Trop Paediatr. 2009 Sep;29(3):197-202.

6. Asnani MR, Fraser R, Lewis NA, Reid ME. Depression and loneliness in Jamaicans with sickle cell disease. BMC Psychiatry. 2010 Jun 07;10:40. PMCID: PMC2894759

7. Boyne MS, Thame M, Osmond C, Fraser RA, Gabay L, Reid M, Forrester TE. Growth, body composition, and the onset of puberty: longitudinal observations in Afro-Caribbean children. J Clin Endocrinol Metab. 2010 Jul;95(7):3194-200.

8. Boyne MS, Osmond C, Fraser RA, Reid M, Taylor-Bryan C, Soares-Wynter S, Forrester TE. Developmental origins of cardiovascular risk in Jamaican children: the Vulnerable Windows Cohort study. Br J Nutr. 2010 Oct;104(7):1026-33.

9. Campbell CP, Barnett AT, Boyne MS, Soares-Wynter S, Osmond C, Fraser RA, Badaloo AV, Taylor-Bryan C, Forrester TE. Predictors of physical activity energy expenditure in Afro-Caribbean children. Eur J Clin Nutr. 2010 Oct;64(10):1093-100.

10. Ali SB, Reid M, Fraser R, MooSang M, Ali A. Seizures in the Jamaica cohort study of sickle cell disease. Br J Haematol. 2010 Nov;151(3):265-72.

11. Serjeant GR, Serjeant BE, Fraser RA, Hambleton IR, Higgs DR, Kulozik AE, Donaldson A. Hb S-β-thalassemia: molecular, hematological and clinical comparisons. Hemoglobin. 2011;35(1):1-12.

12. Asnani MR, Fraser RA, Reid ME. Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease. PLoS One. 2011 Apr 14;6(4):e18863. PMCID: PMC3077410

13. Gordon-Perue G, Gayle F, Fraser R, Ali A. Quality of life of patients with epilepsy living in Kingston, Jamaica. Epilepsy Behav. 2011 May;21(1):23-6.

14. Lawrence-Wright MB, Boyne MS, Osmond C, Fraser RA, Soares-Wynter S, Thame M, Reid M, Taylor-Bryan C, Forrester TE. The effect of feto-maternal size and childhood growth on left ventricular mass and arterial stiffness in Afro-Caribbean children. J Hum Hypertens. 2011 Jul;25(7):457-64.

15. King L, Fraser R, Forbes M, Grindley M, Ali SB, Reid M. Newborn screening in Jamaica: inaccurate reference. Am J Prev Med. 2012 Jun;42(6):e101.

16. Boyne, M. S., Thame, M., Osmond, C., Fraser, R, Gabay, L. A., Taylor-Bryan, C., & Forrester, T. E. (2013). MON-605: The association of puberty with cardiometabolic risk factors in Afro-Caribbean children. Endocrine Society's 95th Annual Meeting-San Francisco.

17. Boyne MS, Thompson DS, Osmond C, Fraser RA, Thame MM, Taylor-Bryan C, Soares-Wynter S, Forrester TE. The effect of antenatal factors and postnatal growth on serum adiponectin levels in children. J Dev Orig Health Dis. 2013 Aug;4(4):317-23.

18. Boyne MS, Thame M, Osmond C, Fraser RA, Gabay L, Taylor-Bryan C, Forrester TE. The effect of earlier puberty on cardiometabolic risk factors in Afro-Caribbean children. J Pediatr Endocrinol Metab. 2014 May;27(5-6):453-60.

19. Gordon-Strachan G, Cunningham-Myrie C, Fox K, Kirton C, Fraser R, McLeod G, Forrester T. Richer but fatter: the unintended consequences of microcredit financing on household health and expenditure in Jamaica. Trop Med Int Health. 2015 Jan;20(1):67-76.

20. Fraser RA, Lipsitz SR, Sinha D, Fitzmaurice GM, Pan Y. Approximate median regression for complex survey data with skewed response. Biometrics. 2016 Dec;72(4):1336-1347. PMCID: PMC5055849

21. Dhakal B, Nelson A, Guru Murthy GS, Fraser R, Eastwood D, Hamadani M, Pasquini M, D'Souza A, Hari P. Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age. Clin Lymphoma Myeloma Leuk. 2017 Mar;17(3):165-172.

22. Mahindra A, Hari P, Fraser R, Fei M, Huang J, Berdeja J, Callander N, Costa L, Diaz MA, Freytes C, Gale RP, Girnius S, Holmberg L, Kharfan-Dabaja M, Kumar S, Kyle R, Lazarus H, Lee C, Maiolino A, Moreb J, Nishihori T, Pawarode A, Saad A, Savani BN, Schriber J, William B, Wirk BM, Krishnan A, Nieto Y, D'Souza A. Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis. Bone Marrow Transplant. 2017 Dec;52(12):1616-1622. PMCID: PMC5859934

23. Dhakal B, Kreuziger LB, Rein L, Kleman A, Fraser R, Aster RH, Hari P, Padmanabhan A. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. Lancet Haematol. 2018 May;5(5):e220-e231. PMCID: PMC6437775

24. Kumar SK, Dispenzieri A, Fraser R, Mingwei F, Akpek G, Cornell R, Kharfan-Dabaja M, Freytes C, Hashmi S, Hildebrandt G, Holmberg L, Kyle R, Lazarus H, Lee C, Mikhael J, Nishihori T, Tay J, Usmani S, Vesole D, Vij R, Wirk B, Krishnan A, Gasparetto C, Mark T, Nieto Y, Hari P, D'Souza A. Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time. Leukemia. 2018 Apr;32(4):986-995. PMCID: PMC5871538

25. Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A. Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups. Biol Blood Marrow Transplant. 2018 Dec;24(12):2443-2449. PMCID: PMC6293469

26. Addesso LC, Nimmer M, Visotcky A, Fraser R, Brousseau DC. Impact of Medical Scribes on Provider Efficiency in the Pediatric Emergency Department. Acad Emerg Med. 2019 Feb;26(2):174-182.

27. Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RP, Kamble R, Diaz MA, Lazarus HM, Savani BN, Hildebrandt GC, Solh M, Freytes CO, Lee C, Kyle RA, Usmani SZ, Ganguly S, Assal A, Berdeja J, Kanate AS, Dhakal B, Meehan K, Kindwall-Keller T, Saad A, Locke F, Seo S, Nishihori T, Gergis U, Gasparetto C, Mark T, Nieto Y, Kumar S, Hari P. Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma. Biol Blood Marrow Transplant. 2019 Apr;25(4):683-688. PMCID: PMC6453717

28. Kilari, D., Hari, P., Qayed, M., Fraser, R., Davila, O., Kumar, S., Mark, T.M., Nieto, Y. and D'Souza, A., 2018. Tandem high-dose chemotherapy and autologous hematopoietic stem cell transplantation (SCT) compared to single SCT for relapsed/refractory germ cell tumors (GCT). Journal of Clinical Oncology 2018 36:6 suppl, 572-572

29. Vyles D, Mistry RD, Heffner V, Drayna P, Chiu A, Visotcky A, Fraser R, Brousseau DC. Reported Knowledge and Management of Potential Penicillin Allergy in Children. Acad Pediatr. 2019 Aug;19(6):684-690.

30. Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P. Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades. Biol Blood Marrow Transplant. 2019 Jun;25(6):1099-1106. PMCID: PMC6559839

31. Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). Lancet Haematol. 2019 Mar;6(3):e132-e143. PMCID: PMC6503965

32. Bemanian A, Cassidy LD, Fraser R, Laud PW, Saeian K, Beyer KMM. Racial disparities of liver cancer mortality in Wisconsin. Cancer Causes Control. 2019 Dec;30(12):1277-1282. PMCID: PMC6858574

33. Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Visotcky A, Fraser R, Pezzin L, Brousseau DC. Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit. J Allergy Clin Immunol Pract. 2020 Mar;8(3):1126-1128.e1. PMCID: PMC7332348

34. Brousseau DC, Muslu CS, Visotcky A, Fraser R, Kavanagh PL, Chelius TH, Schuh AM. Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care. J Pediatr Hematol Oncol. 2020 Aug;42(6):412-413.

35. Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate AS, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes CO, Lee C, Vesole D, Cornell RF, Hildebrandt GC, Murthy HS, Lazarus HM, Cerny J, Yared JA, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D'Souza A. Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia. 2020 Apr 20. doi: 10.1038/s41375-020-0830-0. PMID: 32313109

36. Muslu CS, Kopetsky M, Nimmer M, Visotcky A, Fraser R, Brousseau DC. The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain. Pediatr Blood Cancer. 2020 Sep;67(9):e28268. PMCID: PMC7674235

37. Dhakal B, D'Souza A, Callander N, Chhabra S, Fraser R, Davila O, Anderson K, Assal A, Badawy SM, Berdeja J, Cerny J, Comenzo R, Chakraborty R, Peter Gale R, Kamble R, Kharfan-Dabaja MA, Krem M, Ganguly S, Janakiram M, Kansagra A, Munker R, Murthy H, Patel S, Kumar S, Shah N, Qazilbash M, Hari P. Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma. Br J Haematol. 2020 Nov;191(3):442-452. PMCID: PMC7990054

38. Badar T, Hari P, Dávila O, Fraser R, Wirk B, Dhakal B, Freytes CO, Rodriguez Valdes C, Lee C, Vesole DH, Malek E, Hildebrandt GC, Landau H, Murthy HS, Lazarus HM, Berdeja JG, Meehan KR, Solh M, Diaz MA, Kharfan-Dabaja MA, Callander NS, Farhadfar N, Bashir Q, Kamble RT, Vij R, Munker R, Kyle RA, Chhabra S, Hashmi S, Ganguly S, Jagannath S, Nishihori T, Nieto Y, Kumar S, Shah N, D'Souza A. African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States. Cancer. 2021 Jan 01;127(1):82-92. PMCID: PMC7736245

39. Schroter S, Thomas D, Nimmer M, Visotcky A, Fraser R, Colella MR, Browne LR. Multimedia Evaluation of EMT-Paramedic Assessment and Management of Pediatric Respiratory Distress. Prehosp Emerg Care. 2021;25(5):664-674.

40. Cornell RF, Fraser R, Costa L, Goodman S, Estrada-Merly N, Lee C, Hildebrandt G, Gergis U, Farhadfar N, Freytes CO, Kamble RT, Krem M, Kyle RA, Lazarus HM, Marks DI, Meehan K, Patel SS, Ramanathan M, Olsson RF, Wagner JL, Kumar S, Qazilbash MH, Shah N, Hari P, D'Souza A. Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden Transplantation and Cellular Therapy. 2021.

41. Fraser RA, Lipsitz SR, Sinha D, Fitzmaurice GM. A note on median regression for complex surveys. Biostatistics. 2022 Oct 14;23(4):1074-1082.

42. Bemanian A, Cassidy LD, Fraser R, Laud PW, Saeian K, Beyer KMM. Ecological Study of Variability in the Relationship between Liver Cancer Mortality and Racial Residential Segregation. Int J Environ Res Public Health. 2021 Sep 15;18(18). PMCID: PMC8465489

43. Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate AS, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes CO, Lee C, Vesole D, Cornell RF, Hildebrandt GC, Murthy HS, Lazarus HM, Cerny J, Yared JA, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D'Souza A. Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia. 2021 Jul;35(7):2141.

44. Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate AS, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes CO, Lee C, Vesole D, Cornell RF, Hildebrandt GC, Murthy HS, Lazarus HM, Cerny J, Yared JA, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D'Souza A. Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia. 2021 Jun;35(6):1828. PMCID: PMC8188513

45. Cornell RF, Fraser R, Costa L, Goodman S, Estrada-Merly N, Lee C, Hildebrandt G, Gergis U, Farhadfar N, Freytes CO, Kamble RT, Krem M, Kyle RA, Lazarus HM, Marks DI, Meehan K, Patel SS, Ramanathan M, Olsson RF, Wagner JL, Kumar S, Qazilbash MH, Shah N, Hari P, D'Souza A. Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden. Transplant Cell Ther. 2021 Mar;27(3):264.e1-264.e7. PMCID: PMC8010222

46. Scott BL, Pasquini MC, Fei M, Fraser R, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick E, Fernandez HF, Soiffer RJ, Alyea E, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Hourigan CS, Gui G, Mendizabal A, Horowitz MM, Deeg HJ, Horwitz ME. Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial. Transplant Cell Ther. 2021 Jun;27(6):483.e1-483.e6. PMCID: PMC8217373

47. Bumma N, Dhakal B, Fraser R, Estrada-Merly N, Anderson K, Freytes CO, Hildebrandt GC, Holmberg L, Krem MM, Lee C, Lekakis L, Lazarus HM, Mian H, Murthy HS, Nathan S, Nishihori T, Parrondo R, Patel SS, Solh M, Strouse C, Vesole DH, Kumar S, Qazilbash MH, Shah N, D'Souza A, Sidana S. Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma. Cancer. 2023 Jul 15;129(14):2179-2191. PMCID: PMC10516285

48. Fraser RA. Inappropriate use of statistical power. Bone Marrow Transplant. 2023 May;58(5):474-477.

49. Baumer-Mouradian SH, Hart RJ, Visotcky A, Fraser R, Prasad S, Levas M, Nimmer M, Brousseau DC. Understanding Influenza and SARS-CoV-2 Vaccine Hesitancy in Racial and Ethnic Minority Caregivers. Vaccines (Basel). 2022 Nov 20;10(11). PMCID: PMC9697963

50. Zenga J, Atkinson S, Yen T, Massey B, Stadler M, Bruening J, Peppard W, Reuben M, Hayward M, Mesich B, Buchan B, Ledeboer N, Sanchez JL, Fraser R, Lin CW, Holtz ML, Awan M, Wong SJ, Puram SV, Salzman N. A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiome. EBioMedicine. 2022 Jul;81:104099. PMCID: PMC9168040

51. Kansagra A, Dispenzieri A, Fraser R, Estrada-Merly N, Sidana S, Nishihori T, Hansen DK, Anderson LD Jr., Banerjee R, Bumma N, Dhakal B, Khouri J, Landau H, Lee C, Mian H, Nathan S, Savani B, Kumar S, Qazilbash M, Shah N, D'Souza A. Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma. Blood Adv. 2022 Jul 12;6(13):3991-3995. PMCID: PMC9278304

52. Polhemus S, Pickett ML, Liu XJ, Fraser R, Ferguson CC, Drendel AL. Racial Disparities in the Emergency Department Evaluation of Adolescent Girls. Pediatr Emerg Care. 2022 Jul 01;38(7):307-311.

53. Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L 3rd, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S. Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation? Br J Haematol. 2022 May;197(3):326-338. PMCID: PMC9675037

54. Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD Jr, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, Janakiram M, Lee C, Lekakis L, Murthy HS, Parrondo R, Wangjam T, Usmani S, Shah N, Qazilbash M, D'Souza A. Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplant Cell Ther. 2022 Feb;28(2):83.e1-83.e9. PMCID: PMC8900987

55. Pasvolsky O, Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S, Nagler A, Nishihori T, Parrondo RD, Patel S, Schroeder MA, Usmani SZ, Wang T, Wirk B, Kumar S, Shah N, Qazilbash MH, D'Souza A. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplant. 2022 Jan;57(1):31-37. PMCID: PMC8764606

1. Fraser, RA. The Science of Infinity, Datum, 2016; 22(2): 1-3. Medical College of Wisconsin.

1. Fraser RA, Lipsitz SR, Sinha D, Fitzmaurice GM, Pan Y Median Regression For Complex Survey Data With Skewed Response. 2016 Aug, Joint Statistical Meeting of the American Statistical Association, Chicago, IL.

2. Mahindra A, Hari P, Fraser R, Fei Mingwei, Mark T, Nieto Y, D'Souza, A. Patients with Renal Insufficiency and Multiple Myeloma have Similar Outcomes after Autologous Hematopoietic Cell Transplantation as those without. Oral presentation at 58th Annual Meeting of the American Society of Hematology, Blood 2016

3. Dhakal, B., Hari, P., Rein, L., Fraser, R. and Padmanabhan, A. Use of" Big Data" to Define Disease Burden, Complication Rates and Healthcare Costs in Patients with Heparin-Induced Thrombocytopenia (HIT). 2016, 58th ASH Anual Meeting, 128(22), p. 418.

4. Dispenzieri, A., Kumar, S., Zhang, MJ., Krishnan, A., Gasparetto, C., Nieto, Y., Fraser, R., Huang, J., Hari, P. and D'Souza, A. Trends In Survival Outcomes Among Patients Relapsing Early After Autologous Stem Cell Transplantation For Multiple Myeloma. 2017, BMT Tandem Meetings.

5. Scott E, Harl P, Kumar S, Fraser R, Davila 0, Nieto Y, Mark T, Kumar S, Gasparetto C, D'Souza, A. A Comparison Between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database. Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017.

6. Kumar S, D'Souza, A., Scott E, Fraser R, Davila 0, Gasparetto C, Kumar S, Mark T, Nieto Y, Harl P. Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM). Poster presentation at 59 th Annual Meeting of the American Society of Hematology, Blood 2017.

7. Bolaños-Meade, J., Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadnimi, Z., Alousi, A., Antin, J., Bickett, K., Damon, L., Efebera, Y., Geller, N., Giralt, S., Hari, P., Holtan, S., Horowitz, M., Jacobsohn, D., Jones, R., Liesveld, J., Logan, B., MacMillan, M., Mielcarek, M., Noel, P., Pidala, J., Porter, D., Weisdorf, D., Wu, J., Pasquini, M., and Koreth, J. LBA1 Novel Approaches for Graft-Versus-Host Disease (GvHD) Prophylaxis: Primary Results of Progress I Multicenter Trial of Matched Allogeneic Hematopoietic Cell Transplantation (alloHCT) Using Reduced Intensity Conditioning (RIC). 2018, BMT Tandem Meetings. Renamed Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT) after 2018.

8. Kilari D, Hari P, Qayed M, Fraser R, Davila 0, Kumar S, Mark T, Nieto Y, D'Souza, A. Improved Outcomes with Tandem Autologous Hematopoietic Cell Transplantation (AutoHCT) Compared to Single AutoHCT for Relapsed/Refractory Genn Cell Tumors: A Center for International Blood and Marrow Transplant Research Study. Poster presentation at Annual Genitourinary ASCO Meeting, February 2018.

9. Patel, S, Girnius S, Dhakal B, Gowda L, Fraser R, Davila O, Shah N, Qazilbash M, Kumar, S, D’Souza, A., Hari P. Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation. Oral Presentation at 2019 Annual Meeting of the American Society of Hematology, San Diego, CA.

10. Patel, S, Girnius S, Dhakal B, Gowda L, Fraser R, Davila O, Shah N, Qazilbash M, Kumar, S, D’Souza, A., Hari P. Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation. Oral Presentation at 2019 Annual Meeting of the American Society of Hematology, San Diego, CA.

11. Binod Dhakal, Fraser Raphael, Zhubin Gahvari, Aric Hall, Natalie Callander, Saurabh Chhabra, Omar Davila Alvelo, Shaji Kumar, Nina Shah, Muzaffar Qazilbash, Anita D’Souza, Parameswaran Hari. Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Presented at ASH 2019 as an oral.

12. Theresa E. Hahn, Paul K Wallace, Raphael Fraser, Mingwei Fei, Joseph D Tario, Alan Howard, Yali Zhang, Beth Blackwel, Claudio G. Brunstein, Yvonne A. Efebera, Nancy Geller, Sergio A. Giralt, Parameswaran Hari, Kristin Knust, John Koreth, Amrita Krishnan, Heather Landau, Nina Shah, George Somlo, Edward A. Stadtmauer, Dan T. Vogl, David H. Vesole, Philip L. McCarthy and Marcelo C. Pasquini. Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study. Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT) 2019

13. Cornell RF, Hari P, Costa L, Goodman S, Fraser R, Estrada-Merly N, Kumar S, Qazilbash M, D’Souza, A. Brotezomib induction prior to autologous hematopoietic cell transplantation (AHCT) for newly diagnosed light chain amyloidosis (AL): A study of 426 patients. Poster Presentation with discussion at 2020 Annual Meeting of the American Society of Clinical Oncology, Virtual Meeting.

14. Abou-Ismail MY, Metheny L, Fraser R, Johnson MH, Ravi G, de Lima M, Pasquini MC, Savani B, Sorror ML, Stadtmauer EA, Chhabra S. Effect of Obesity on Outcomes after Alternative Donor Allogeneic Hematopoietic Stem Cell Transplant (alloHCT). In2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2021 Feb 8. Tandem Meetings.

15. Bumma N, Dhakal B, Fraser R, Estrada-Merly N, Kumar S, Shah N, Qazilbash MH, D'Souza A, Sidana S. Impact of bortezomib-based vs. lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma. In 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2022 Apr 23. Tandem Meetings.